Tens of thousands of Kaiser Permanente workers in California and Hawaii have gone on strike, demanding safer staffing levels ...

CMS Administrator Dr. Mehmet Oz said that Medicaid’s rapid spending growth is unsustainable and criticized state financing ...

Insurers are cutting coverage for costly GLP-1 weight loss drugs, sparking backlash from advocates who say they're vital for ...

With $50 billion set to flow to states over the next five years, CMS’ new Rural Health Transformation Program represents one of the largest federal investments in rural healthcare in decades. However, ...

Providence and Humana have teamed up to launch a new data exchange program to improve value-based care. Their project, announced on Monday, seeks to enable secure and standardized clinical data ...

Novo Nordisk is paying $240 million up front for global rights to zaltenibart, an Omeros drug that blocks the MASP-3 protein to treat diseases caused by excessive activity of the complement system.

Healthcare staff members are finding Artera’s AI copilots helpful and easy to use after six months of real-world deployment. Artera, a digital health software company based in Santa Barbara, launched ...

Withings Health Solutions, a company offering health monitoring devices, has added Ilant Health to its Obesity Care Management Partner Ecosystem. It also released its best practices for obesity ...

Lung cancer can be treated with small molecules formulated as pills as well as biological medications that are injected or infused, both as standalone treatments or as part of drug combinations. A ...

The use of AI in healthcare is rapidly growing, but physicians are often left out of the conversation about how these technologies should be implemented effectively. That’s why the American Medical ...

Takeda Pharmaceutical is bolstering its pipeline in a big way, committing $1.2 billion for rights to two late-stage Innovent Biologics cancer drugs and securing an exclusive option to license an early ...

A Roche drug that is one of the company’s top cancer products is expanding to autoimmune disease with a new FDA approval in lupus nephritis. The intravenously infused drug, Gazyva, may now be used to ...